Fecal Microbiota
Transplantation.
Restoring the gut ecosystem through specialist-led care.
FMT is a clinically supervised microbiota-based intervention used primarily for carefully selected patients with recurrent Clostridioides difficile infection. WEmedical coordinates expert review, hospital communication, translation, and follow-up in Seoul.FMT is a clinically supervised microbiota-based intervention used primarily for carefully selected patients with recurrent Clostridioides difficile infection. WEmedical coordinates expert review, hospital communication, translation, and follow-up in Seoul.
81%
Symptom resolution after the first FMT infusion
NEJM 2013 · Vancomycin groups: 23–31%
Whole-Body Wellness Support
Connects fatigue, skin condition, and inflammatory signals with digestive health.
Gut Function Rebuilding
Reviews persistent digestive concerns from the underlying intestinal environment.
A Healthier Gut Environment
Considers the intestinal barrier and microbial balance together.
Wellness-support descriptions reflect a coordinated assessment perspective and are not established FMT indications. Treatment eligibility is determined by a qualified gastroenterology specialist.Wellness-support descriptions reflect a coordinated assessment perspective and are not established FMT indications. Treatment eligibility is determined by a qualified gastroenterology specialist.
Not stool itself — a screened and processed
microbial ecosystem.
Fecal Microbiota Transplantation precisely extracts and processes the intestinal microbial community of a healthy, carefully qualified donor, then delivers that microbiota-based preparation into the patient’s gastrointestinal tract.
Rigorous donor qualification, detailed infectious-disease testing, stool analysis, and standardised preparation protocols are used to reduce transmissible risk. Only material that has passed the treating provider’s required safety and quality checks is considered for use.
Important: FMT is not a general detox, anti-ageing therapy, or universal treatment for digestive symptoms. Every case requires diagnosis and individual specialist assessment.
Evidence first. Always.
Clear expectations are part of safe care. The current evidence is strongest in recurrent C. difficile infection; other uses remain investigational.
Established clinical use
Recurrent C. difficile infection
Guidelines support microbiota-based therapies for appropriately selected adults with recurrent infection after standard-of-care antibiotics, with important exceptions for some severely immunocompromised patients.
Clinical-trial territory
IBD, IBS & other conditions
Routine conventional FMT is not recommended for ulcerative colitis, Crohn’s disease, pouchitis, or irritable bowel syndrome outside clinical trials. Your specialist can explain appropriate evidence-based alternatives.
Frequently Asked Questions
Clear answers before care.
Will I experience pain, discomfort, or an unpleasant odour during the procedure?
The procedure is generally performed using sedated endoscopy under the close monitoring of an experienced medical team, so most patients do not experience significant pain or discomfort during treatment. Because the microbiota preparation undergoes medical processing before use, noticeable odour or unpleasant sensations during the procedure are also uncommon.
Can I return to daily activities or work immediately after the procedure?
Most patients can return home the same day after resting and being monitored in the recovery area. However, following sedated endoscopy, you should avoid driving, alcohol, strenuous exercise, and important decisions for the rest of the day. Plan to rest, follow the hospital’s discharge instructions, and arrange an escort if required.
Can I expect results from a single treatment?
Response varies according to each patient’s existing gut environment, symptom duration, underlying conditions, and treatment history. A single-session programme can serve as a starter course to assess initial response and suitability. Where the gut environment has been disrupted for a long period, the specialist may discuss a repeat-administration strategy, such as a three-session rebuilding programme, only when clinically appropriate.
When might I begin to notice a treatment response?
Some patients notice changes in bowel rhythm, gas, or abdominal bloating within several days. Responses are individual and are not guaranteed. The transferred microbial community may require several weeks to adapt to and stabilise within the patient’s intestinal environment, and clinical follow-up remains important.
Is ordinary stool from a healthy person transferred directly?
No. FMT does not involve directly administering ordinary stool. It uses a microbiota-based preparation produced through donor qualification, infectious-disease screening, stool testing, and controlled processing. Participating medical providers use preparations that have passed the verification protocols of a specialist stool bank or an equivalent qualified source.
Helping a disrupted gut ecosystem
recover a healthier balance.
FMT aims to support ecological recovery inside the intestine. The degree of microbial engraftment and clinical response varies from person to person.
Why imbalance occurs
Antibiotics, infection, inflammation, and dietary factors can disrupt the intestinal ecosystem and weaken natural colonisation resistance.
The restoration mechanism
A screened microbial community is delivered to support microbial diversity, compete with harmful organisms, and help restore key microbial metabolites.
Individual response matters
Engraftment and clinical response vary with the baseline microbiome, underlying conditions, diet, symptoms, and antibiotic history.
From records to
responsible follow-up.
Specialist review
A gastroenterologist reviews your diagnosis, recurrence history, antibiotic treatment, immune status, medications, and previous test results.
Eligibility & safety screening
The medical team confirms whether FMT is appropriate and discusses alternatives, contraindications, potential benefits, and known risks.
Donor material preparation
Material must come from a rigorously screened source following the treating hospital’s protocol for infectious and transmissible risks.
Clinician-directed delivery
The route and preparation plan are selected by the treating specialist. Depending on the clinical setting, delivery may be lower-GI, upper-GI, or oral microbiota-based therapy.
Recovery & follow-up
Your care team monitors symptoms, provides clear aftercare instructions, and arranges follow-up if symptoms recur or warning signs appear.
A medical procedure,
not a shortcut.
FMT can transmit infectious organisms and may cause serious adverse reactions. It should only be considered with a qualified clinician, rigorous screening, informed consent, and a clear follow-up plan.
Individual eligibility
Severe immunocompromise and other clinical factors may change whether microbiota-based therapy is appropriate.
Informed consent
The treating team should explain the procedure’s status, alternatives, uncertainties, benefits, and potential harms.
Warning signs
Fever, severe abdominal pain, persistent vomiting, bleeding, or worsening diarrhoea after treatment require prompt medical attention.
Care without the language barrier.
Records prepared
We organise your diagnosis, laboratory results, treatment history, and imaging for efficient specialist review.
Medical interpretation
Multilingual coordination helps you understand the consultation, consent discussion, and aftercare instructions.
End-to-end logistics
Hospital scheduling, local transport coordination, and follow-up communication are managed around your care plan.
Start with the right
specialist review.
Share your medical history securely with our concierge team. We will help coordinate an eligibility review with an appropriate gastroenterology provider in Seoul. Treatment availability and suitability are determined by the treating medical team.
This page provides general educational information and does not replace diagnosis or advice from a qualified medical professional.